Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Cephalon Inc. et al v. Mylan Pharmaceuticals Inc. et al
Case Number:
1:11-cv-00164
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 22, 2013
Mylan Infringed Cephalon Painkiller Patents, Judge Says
A Delaware federal judge on Monday ruled that Mylan Pharmaceuticals Inc. infringed three patents for Cephalon Inc.'s cancer painkiller drug Fentora, saying the former company's proposed generic version of the drug includes components covered by the patents.
-
February 28, 2011
Cephalon, Cima Sue Mylan To Block Generic Fentora
Cephalon Inc. and Cima Labs Inc. launched a patent infringement suit against Mylan Inc. in Delaware on Friday, targeting the company over its attempts to market a generic version of Cephalon's cancer painkiller drug Fentora.